国邦医药：11月6日召开董事会会议

Group 1 - The core point of the article is that Guobang Pharmaceutical held its first temporary board meeting for 2025 on November 6, 2023, to discuss the appointment of the board secretary and other documents [1] - For the year 2024, Guobang Pharmaceutical's revenue composition is as follows: the pharmaceutical segment accounts for 64.87%, the animal health products segment accounts for 34.24%, and other segments account for 0.48% and 0.4% respectively [1] - As of the report date, Guobang Pharmaceutical has a market capitalization of 12.5 billion yuan [1]